Back to search

Article

Estimating the Global Market Size for Disease-Modifying Therapies in Epilepsy Caused by Haploinsufficiency

2025-01-22

Abstract excerpt

<h4>Importance</h4> Haploinsufficiency, a condition where a single functional copy of a gene is insufficient to maintain normal physiological function due to a mutation, represents the most prevalent disease mechanism underlying genetic epilepsies, particularly developmental and epileptic encephalopathies (DEEs). Current therapies for these patients primarily address symptoms and fail to alter the disease trajecto...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7196b154-42fb-5a90-8c18-e91e692059cd
DOI
10.1101/2025.01.20.25320871
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Estimating the Global Market Size for Disease-Modifying Therapies in Epilepsy Caused by HaploinsufficiencyDOI 10.1101/2025.01.20.25320871
Select a neighboring publication to make it the new centre.